PAPaulo Abreu

Paulo Abreu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paulo Abreu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Upper Respiratory Tract Infections and Rhino-Pharyngeal Clearance in Children: Myths and Clinical Evidence for a Pictorial Essay

    by Ana Silva Alexandrino, David Tome, Paulo Abreu, Şule Çekiç, Patrícia Carvalho

    Upper respiratory tract infections (URTI) have a high incidence in young children leading to Eustachian tube dysfunction and middle ear impairment, due to anatomical and physiological connections between these structures. In the last years, pharmacological treatments started to be avoided. Moreover, there is no evidence of an effective pharmacological treatment of URTI in children, since antibiotics are not recommended, neither narcotics, antihistamines nor decongestants. So, an effective rhino-pharyngeal clearance could avoid the deleterious evolution of the health condition of the child by reducing or eliminating nasal secretions, re-establishing nasal breathing, and preventing dissemination which may result in bacterial infection. Several studies have underpinned the benefits and immediate effects of rhino-pharyngeal clearance, such has the improvement of nasal obstruction and middle ear pressure in tympanogram in children under 3 years of age with URTI. However, a consensus on the next research trends and clinical trials are required to establish and implement efficient protocols with adequate treatment monitoring and outcome measures. This article aims to highlight the best evidence, clarify some goals among different areas of expertise, and suggest future research.

  • Expiratory Flow Maneuvers in Patients with Neuromuscular Diseases

    by John R Bach, Miguel R Gonçalves, Sylvia Páez, João Carlos Winck, Sandra Leitão, Paulo Abreu

    Bach JR, Gonçalves MR, Páez S, Winck JC, Leitão S, Abreu P: Expiratory flow maneuvers in patients with neuromuscular diseases. Am J Phys Med Rehabil 2006;85:105–111. Objectives: To compare cough peak flows (CPF), peak expiratory flows (PEF), and potentially confounding flows obtained by lip and tongue propulsion (dart flows, DF) for normal subjects and for patients with neuromuscular disease/restrictive pulmonary syndrome and to correlate them with vital capacity and maximum insufflation capacity. Design: A cross-sectional analytic study of 125 stable patients and 52 normal subjects in which CPF, PEF, and DF were measured by peak flow meter and vital capacity and maximum insufflation capacity by spirometer. Results: In normal subjects and in patients, the DF significantly exceeded PEF and CPF (P ≤ 0.001). For normal subjects, PEF and CPF were not significantly different. For patients with neuromuscular disease/restrictive pulmonary syndrome, the CPF significantly exceeded PEF (P < 0.05). No normal subjects but 14 patients had DF lower than CPF. Thirteen of these 14 had the ability to air stack (maximum insufflation capacity greater than vital capacity), indicating greater compromise of mouth and lip than of glottic muscles. For 14 of 88 patients, maximum insufflation capacity values did not exceed vital capacity, mostly because of inability to close the glottis (inability to air stack). Nonetheless, for 11 of these 14 patients, the DF were within a standard deviation of the whole patient group; thus, bulbar-innervated muscle dysfunction was not uniform. CPF and PEF correlated with vital capacity (r = 0.85 and 0.86, respectively), and with maximum insufflation capacity (r = 0.76 and 0.72, respectively). Conclusions: Measurements of CPF, PEF, and DF are useful for assessing bulbar-innervated, inspiratory, and expiratory muscle function. Care must be taken to not confuse them.